Cancer, not cardiovascular disease, is the leading cause of death in type 2 diabetes, a new study has found. This breaks the conventional wisdom that the cause of death in diabetes is a cardiovascular disease complication, suggesting the need for a multidisciplinary approach. The results of a study on the mortality rate of patients with … Read more
The side effect issue of diabetic retinopathy (DR) of type 2 diabetes treatment glucagon-like peptide-1 receptor agonist (GLP-1 RA) has been reconfirmed. At the time of the development of semaglutide, an increase in retinopathy patients was observed in clinical trials, but as a similar trend was found in a meta-analysis involving a total of 60,000 … Read more
Studies have shown that high-density lipoprotein (HDL-C), the cholesterol that is good for cardiovascular health, is negative for bone health. For cardiovascular health, high HDL-C is good, but for bone health, it means you need to find the right trade-off. The results of a study on the association between plasma HDL-C levels and fracture risk, … Read more
Studies have shown that high-density lipoprotein (HDL-C), the cholesterol that is good for cardiovascular health, is negative for bone health. For cardiovascular health, high HDL-C is good, but for bone health, it means you need to find the right trade-off. The results of a study on the association between plasma HDL-C levels and fracture risk, … Read more
Thanks to artificial intelligence, researchers have been able to identify, in adolescents, the warning signs of the onset of anxiety disorders in early adulthood. A new study, conducted by scientists from the National Institute of Health and Medical Research (Inserm), the National Center for Scientific Research (CNRS), the École Normale Supérieure and the University of … Read more
Paljinhoe, a representative meeting of seniors in the pharmaceutical industry, has concluded their 48-year partnership. Paljinhoe is a friendly gathering established in 1975 by eight owners and managers of major domestic pharmaceutical companies with the intention of ‘let’s move forward together as eight people’. The Paljinhoe, a meeting of elders in the pharmaceutical industry, concluded … Read more